Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Repetto

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Cancers|September 9, 2022
Targeting Cellular Components of the Tumor Microenvironment in Solid MalignanciesCarmen Belli, Gabriele Antonarelli, Matteo Repetto, et al.
Investigational New Drugs|May 25, 2022
The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046Matteo Repetto, Edoardo Crimini, Liliana Ascione, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2023
A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing dataMatteo Repetto, Edoardo Crimini, Carmen Belli, et al.
Cancers|July 9, 2022
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor BoardsEdoardo Crimini, Matteo Repetto, Paolo Tarantino, et al.
Cancer Investigation|October 30, 2020
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the LiteratureLaura Pala, Fabio Conforti, Emilia Cocorocchio, et al.
Trends in Cancer|September 13, 2023
Variant allele frequency: a decision-making tool in precision oncology?Luca Boscolo Bielo, Dario Trapani, Matteo Repetto, et al.
NPJ Precision Oncology|August 8, 2024
TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
Chirurgia (Bucharest, Romania : 1990)|December 30, 2021
Systemic Treatment of Ductal Carcinoma In Situ of the BreastEdoardo Crimini, Chiara Corti, Matteo Repetto, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
TKI Type Switching Overcomes ROS1 L2086F in ROS1 Fusion-Positive CancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
Cancers|January 23, 2024
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor TargetingEdoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Cancers|September 9, 2022
Targeting Cellular Components of the Tumor Microenvironment in Solid MalignanciesCarmen Belli, Gabriele Antonarelli, Matteo Repetto, et al.
Investigational New Drugs|May 25, 2022
The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046Matteo Repetto, Edoardo Crimini, Liliana Ascione, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2023
A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing dataMatteo Repetto, Edoardo Crimini, Carmen Belli, et al.
Cancers|July 9, 2022
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor BoardsEdoardo Crimini, Matteo Repetto, Paolo Tarantino, et al.
Cancer Investigation|October 30, 2020
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the LiteratureLaura Pala, Fabio Conforti, Emilia Cocorocchio, et al.
Trends in Cancer|September 13, 2023
Variant allele frequency: a decision-making tool in precision oncology?Luca Boscolo Bielo, Dario Trapani, Matteo Repetto, et al.
NPJ Precision Oncology|August 8, 2024
TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
Chirurgia (Bucharest, Romania : 1990)|December 30, 2021
Systemic Treatment of Ductal Carcinoma In Situ of the BreastEdoardo Crimini, Chiara Corti, Matteo Repetto, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
TKI Type Switching Overcomes ROS1 L2086F in ROS1 Fusion-Positive CancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
Cancers|January 23, 2024
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor TargetingEdoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, et al.
Pageof 5